iA Global Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Buy
42,263
+4,625
+12% +$1.96M 0.2% 103
2026
Q1
$17.8M Sell
37,638
-5,183
-12% -$2.61M 0.25% 84
2025
Q4
$20M Sell
42,821
-2,243
-5% -$1.04M 0.25% 87
2025
Q3
$19.2M Buy
45,064
+5,136
+13% +$1.99M 0.26% 80
2025
Q2
$15.3M Buy
39,928
+29,368
+278% +$10.6M 0.23% 86
2025
Q1
$3.65M Sell
10,560
-4,364
-29% -$1.4M 0.06% 186
2024
Q4
$4.48M Buy
14,924
+7,699
+107% +$2.69M 0.08% 173
2024
Q3
$2.94M Sell
7,225
-42
-0.6% -$15.4K 0.05% 213
2024
Q2
$2.33M Sell
7,267
-436
-6% -$142K 0.04% 218
2024
Q1
$2.57M Sell
7,703
-1,298
-14% -$397K 0.05% 217
2023
Q4
$2.44M Sell
9,001
-814
-8% -$201K 0.06% 226
2023
Q3
$2.41M Buy
9,815
+499
+5% +$137K 0.06% 207
2023
Q2
$2.83M Buy
+9,316
New +$2.59M 0.08% 199

Other funds holding HCA

iA Global Asset Management's HCA Position: Q2 2026 in Review

iA Global Asset Management increased its HCA Healthcare (HCA) stake by 12% in Q2 2026, buying an estimated $1.96M and bringing the position to 42,263 shares worth $16.5M. The position accounts for 0.2% of the portfolio, ranked #103.

iA Global Asset Management first reported a position in HCA in Q2 2023 and has held it in 13 quarters since. The position peaked at $20M in Q4 2025. 1,337 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • iA Global Asset Management held 42,263 shares of HCA Healthcare worth $16.5M as of Q2 2026.
  • iA Global Asset Management bought 4,625 HCA Healthcare shares in Q2 2026, an estimated $1.96M.
  • HCA Healthcare made up 0.2% of iA Global Asset Management's portfolio in Q2 2026, its #103 holding.
  • iA Global Asset Management first reported a position in HCA Healthcare in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's HCA Healthcare position peaked at $20M in Q4 2025.
  • 1,337 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.